Company Filing History:
1 out of 832,912 Years Active: 2001
Title: The Innovations of Sadek Bassem
Introduction
Sadek Bassem is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of chemistry, particularly in the development of novel compounds with therapeutic applications. His work focuses on histamine receptors, which play a crucial role in various physiological processes.
Latest Patents
Sadek Bassem holds a patent for "Imidazole derivatives as histamine receptor H3 (ANT) agonists." This patent includes novel imidazole derivatives that serve as histamine receptor H antagonists and/or agonists. The patent outlines the preparation of these compounds and their therapeutic uses. It also describes chemical compounds that act as histamine receptor H agonists, partial agonists, or antagonists, characterized by general formulas (Ia) or (Ib). The patent further details methods for revealing the agonist, partial agonist, or antagonist activity of such compounds in vivo.
Career Highlights
Throughout his career, Sadek Bassem has demonstrated a commitment to advancing scientific knowledge and developing innovative solutions in pharmacology. His research has the potential to lead to new treatments for various conditions related to histamine receptors.
Collaborations
Sadek Bassem has collaborated with esteemed colleagues such as Jean-Charles Schwartz and Jean-Michel Arrang. These partnerships have contributed to the depth and breadth of his research, enhancing the impact of his work in the scientific community.
Conclusion
Sadek Bassem's contributions to the field of chemistry and pharmacology are noteworthy. His innovative work on imidazole derivatives showcases his dedication to developing new therapeutic options. The impact of his research continues to resonate within the scientific community.